These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37304203)

  • 21. Does serum cystatin C level reflect insulin resistance in patients with type 1 diabetes?
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Wegner M; Grzelka A; Wierusz-Wysocka B
    Clin Biochem; 2014 Sep; 47(13-14):1235-8. PubMed ID: 24956263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review.
    Norris KC; Smoyer KE; Rolland C; Van der Vaart J; Grubb EB
    BMC Nephrol; 2018 Feb; 19(1):36. PubMed ID: 29426298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.
    Nyström T; Holzmann MJ; Eliasson B; Svensson AM; Kuhl J; Sartipy U
    Heart Vessels; 2017 Mar; 32(3):269-278. PubMed ID: 27401741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin.
    Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA
    Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
    Sugiyama S; Jinnouchi H; Yoshida A; Hieshima K; Kurinami N; Jinnouchi K; Tanaka M; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
    J Clin Med Res; 2019 Apr; 11(4):267-274. PubMed ID: 30937117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus.
    Li Z; Qi C; Jia Z; Zhen R; Ren L; Jia Y; Chen S
    Diabetes Metab Syndr Obes; 2022; 15():2643-2652. PubMed ID: 36071794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study.
    Zabala A; Darsalia V; Lind M; Svensson AM; Franzén S; Eliasson B; Patrone C; Jonsson M; Nyström T
    Cardiovasc Diabetol; 2021 Oct; 20(1):202. PubMed ID: 34615525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.
    Liu JJ; Liu S; Wong MD; Gurung RL; Lim SC
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3794-3802. PubMed ID: 27459536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study.
    Spanopoulos D; Okhai H; Zaccardi F; Tebboth A; Barrett B; Busse M; Webb J; Khunti K
    Diabetes Obes Metab; 2019 Aug; 21(8):1817-1823. PubMed ID: 30941882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study.
    Ren X; Jiang M; Han L; Zheng X
    BMC Geriatr; 2022 Dec; 22(1):968. PubMed ID: 36517754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
    Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta-analysis.
    Wang C; Zhou Y; Kong Z; Wang X; Lv W; Geng Z; Wang Y
    Diabetes Obes Metab; 2019 Apr; 21(4):1018-1026. PubMed ID: 30565382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effect of additional sodium-glucose cotransporter 2 inhibitor therapy in type 2 diabetes patients with rapid decline and preserved renal function.
    Sada K; Hidaka S; Kashima J; Morita M; Sada K; Shibata H
    J Diabetes Investig; 2022 Aug; 13(8):1330-1338. PubMed ID: 35322583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of estimated glucose disposal rate to detect prevalent left ventricular hypertrophy: implications from a general population.
    Shi W; Qin M; Wu S; Xu K; Zheng Q; Liu X
    Postgrad Med; 2023 Jan; 135(1):58-66. PubMed ID: 36174224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years.
    Fountoulakis N; Thakrar C; Patel K; Viberti G; Gnudi L; Karalliedde J
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis.
    O'Mahoney LL; Kietsiriroje N; Pearson S; West DJ; Holmes M; Ajjan RA; Campbell MD
    J Endocrinol Invest; 2021 Nov; 44(11):2417-2426. PubMed ID: 33730349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.
    Miyoshi H; Kameda H; Yamashita K; Nakamura A; Kurihara Y
    J Diabetes Investig; 2019 Nov; 10(6):1510-1517. PubMed ID: 31026373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of serum C-peptide are associated with a decreased risk for incident renal progression in patients with type 2 diabetes: a retrospective cohort study.
    Yang Q; Liu Y; Peng J; Pan J; Chen L; Cui J; Yi B
    BMJ Open Diabetes Res Care; 2023 Mar; 11(2):. PubMed ID: 36958752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Kemmner S; Bachmann Q; Angermann S; Wen M; Heemann U; Renders L; Garimella PS; Scherberich J
    Medicine (Baltimore); 2019 May; 98(21):e15808. PubMed ID: 31124979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.